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Absolute numbers of B, T, and NK cells in peripheral blood and 
percentages of precursor B cells and mature CD22+ B cells in BM 
of patient SC2 compared with RAG-deficient and Artemis-defi-
cient SCID patients and healthy controls
	 	 Patient		 RAG-		 Artemis-	 Healthy	
	 	 SC2	 deficient		 deficient	 controls	
	 	 	 SCID	 SCID	 (9–15	mo)
Peripheral blood  n = 3 n = 3 n = 70A
 B cells (× 109/l) 0.01 0.001 0.001 0.6–2.7
 T cells (× 109/l)B 0.23 0.20 0.51 1.6–6.7
 NK cells (× 109/l) 0.5 1.12 1.11 0.2–1.2
BM  n = 7 n = 4 n = 6
 % Precursor CD22+ BC 11 32 ± 24 17 ± 14 31 ± 10
 % Mature CD22+ BD 0.1 0.009 ± 0.01 0.004 ± 0.003 19 ± 5
ASee ref. 49. BT cells of SCID patients can be autologous or mater-
nal (50). T cells of patient SC2 were autologous. CThe percentage of 
precursor B cells was calculated by subtraction of the percentage of 
mature SmIgM+SmIgD+ B cells from the total percentage of CD22+ B 
cells within the flow cytometric lymphogate (16, 44, 51). DWithin the flow 
cytometric lymphogate.
Figure 1
Clonogenic survival assay of fibroblasts after IR. Fibroblasts from 
patient SC2, the Artemis-deficient SCID patient (Artemis-1), and the 
NBS1-LBI cell line with an NBS1 mutation were radiosensitive. WT 
FN1 fibroblasts were used as normal control. Each survival curve rep-
resents the mean of at least 3 independent experiments. Error bars 
represent SEM.
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IRIF formation in patient SC2 fibroblasts. (A) WT primary human fibroblasts and patient SC2 primary fibroblasts were untreated or γ irradiated 
with increasing doses (1, 2, 4, 6, 8, 10, and 12 Gy) and fixed after an incubation period of 8 hours followed by immunostaining with the MRE11 
or γ-H2AX antibodies. (B) Kinetics of loss of γ-H2AX foci in fibroblasts derived from patient SC2 and the LIG4-defective patients 180BR (a radio-
sensitive leukemia patient) and 411BR (a patient with the LIG4 syndrome), and WT FN1 cells, following x-ray irradiation (1 Gy). The number of 
foci per nucleus was determined in 40 cells at the indicated times after irradiation.
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Flow cytometric analysis of BM precursor B cell compartment. 
Composition of the BM precursor B cell compartment in the 
patient, healthy controls (n = 6), RAG-deficient SCID patients 
(n = 7), Artemis-deficient patients (n = 4), and patient SC2. 
RAG-deficient and Artemis-deficient SCID patients showed a 
complete block before the CyIgµ-positive pre-B-II cell stage, 
whereas patient SC2 showed an incomplete block, with 
approximately 20% pre-B-II and immature B cells.
Table 2
Sequences of DH-JH junctions derived from BM mononuclear 
cells of patient SC2 and healthy donors
Patient	SC2	
DH	segment	 3′	deletion	 N	nucleotides	 5′	deletion	 JH	segment
DH2–21 0 G –7 JH4
DH5–24 –13 – –20 JH6
DH2–2 –2 G –20 JH4
DH2–15 –9 CTGT –15 JH5
DH3–9 –12 C –2 JH2
DH2–15 –14 CG –8 JH4
DH4–11 –16 – –19 JH4A
DH4–17 –5 GCCT –14 JH5
DH4–23 –12 – –29 JHA,B
DH5–12 –2 GGG –9 JH2
DH5–24 –62 GGA –32 JHB
DH5–24 –9 TCGGACAC –19 JH4
DH5–12 –2 CGGTGACA –14 JH4
Average –12.2 ± 15.9 2.8 –16.0 ± 8.5
Healthy	controls	
DH	segment	 3′	deletion	 N	nucleotides	 5′	deletion	 JH	segment
DH3–10 –4 ACCTAACAGAAAGA –5 JH6
DH2–2 –6 CCCCTTC –6 JH5
DH2–21 –3 AT –5 JH5
DH2–2 –3 C 0 JH5
DH3–22 –5 TAAC –6 JH4
DH5–18 –6 CAACA –7 JH4
DH2–21 –5 GAAAGCCCT –4 JH6
DH5–18 –1 TGG –5 JH5
DH2–15 –3 C 0 JH5
DH4–17 –3 CCCC –11 JH6
DH4–11 0 ACTCGAAGACCC –2 JH6
DH5–12 0 TAT –9 JH4
DH5–12 –2 TGA –9 JH4
DH5–12 –2 CCCTATTACCATT –5 JH6
DH5–24 –4 AGCT –21 JH6
Average –3.1 ± 1.9 5.7 –6.3 ± 5.1
AMicrohomology of 1 nucleotide. BJH could not be assigned because of 
the size of the deletion; all JH gene segments are identical in this region.
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Sequences of signal joints derived from BM mononuclear cells of patient SC2
	 Signal	jointsA	 Deletions	 Insertions





1	 ACGGGCAGCAGGTTGGCAGCGCACA-----	-------------------------AGGGA	 30	 T
1	 ACGGGCAGCAGGTTGGCAGCGCACACTGT-	CACAGTGATACAAATAATGCCACTAAGGGA	 1
1	 ACGGGCAGCAGGTTGGCAGCGCACACTGTG	CACAGTGATACAAATAATGCCACTAAGGGA	 0	 CACACACACA
ABolded nucleotides indicate the heptamer sequences of the RSS in the control sequence; underlined nucleotides are involved in repair via micro-
homology. BSequence of a precise signal joint formed after the rearrangement of IntronRSS-Kde as found in controls. CNumber of clones found with 
the indicated type of signal joint.
Figure 4
DNA end joining. (A) A linear substrate with homologous ends 
(ATCAGC) can be rejoined via direct end joining or via microhomol-
ogy-directed end joining. Joining via microhomology results in the gen-
eration of a BstXI restriction site (CCAN6TGG). (B) Analysis of joining 
products in WT (Normal), SC2, Artemis (Artemis-1), and LIG4 mutant 
(180BR) cells. Junctions were PCR amplified, and PCR products were 
digested with BstXI, as indicated.
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Analysis of LIG4 protein expression. (A) Western blot analysis of LIG4 
protein expression showed absence of an approximately 100-kDa band 
in patient SC2. Artemis-1 was used as positive control. The position of 
the 100-kDa band of the molecular weight marker is indicated on the 
left. (B) After immunoprecipitation of the LIG4/XRCC4 complex with the 
XRCC4 antibody, no LIG4 protein was detectable in patient SC2.
Figure 6
Complementation of end-joining defect with the WT LIG4. Analysis of 
joining products of the linear substrate with homologous ends (Figure 4A) 
in WT and SC2 patients with and without cotransfection of a WT LIG4 
expression construct. Junctions were PCR amplified, and PCR prod-
ucts were digested with BstXI, as indicated.
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